Julia Y. Cui, Ph.D.
Affiliations: | 2010 | Pharmacology, Toxicology & Therapeutics | University of Kansas, Lawrence, KS, United States |
Area:
Toxicology, Pharmacology, Molecular BiologyGoogle:
"Julia Cui"Parents
Sign in to add mentor| Curtis D. Klaassen | grad student | 2010 | University of Kansas | |
| (Developmental regulation of the drug-processing genome in mouse liver.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Li X, Wang H, Wang H, et al. (2024) Germ-free Status but Not Subacute Polychlorinated Biphenyl (PCB) Exposure Altered Hepatic Phosphatidylcholine and Ether-Phosphatidylcholine Levels in Mice. Toxicology. 153790 |
| Wang H, Zhang L, Xia Z, et al. (2022) Effects of chronic cadmium exposure on brain and liver transporters and drug-metabolizing enzymes in male and female mice genetically predisposed to Alzheimer's disease. Drug Metabolism and Disposition: the Biological Fate of Chemicals |
| Zhang A, Matsushita M, Zhang L, et al. (2021) Cadmium exposure modulates the gut-liver axis in an Alzheimer's disease mouse model. Communications Biology. 4: 1398 |
| Dutta M, Lim JJ, Cui JY. (2021) . Drug Metabolism and Disposition: the Biological Fate of Chemicals |
| Lim JJ, Suh Y, Faustman EM, et al. (2021) Regulation of transporters by perfluorinated carboxylic acids in HepaRG cells. Drug Metabolism and Disposition: the Biological Fate of Chemicals |
| Ioannou GN, Lee SP, Linsley PS, et al. (2021) Pcsk9 Deletion Promotes Murine Nonalcoholic Steatohepatitis and Hepatic Carcinogenesis: Role of Cholesterol. Hepatology Communications |
| Fu ZD, Selwyn FP, Cui JY, et al. (2021) RNA-Seq unveiled section-specific host response to lack of gut microbiota in mouse intestine. Toxicology and Applied Pharmacology. 115775 |
| Kim S, Choi S, Dutta M, et al. (2021) Pregnane X receptor exacerbates nonalcoholic fatty liver disease accompanied by obesity- and inflammation-prone gut microbiome signature. Biochemical Pharmacology. 114698 |
| Li N, Koester ST, Lachance DM, et al. (2021) Microbiome-encoded bile acid metabolism modulates colonic transit times. Iscience. 24: 102508 |
| Liu J, Cui JY, Lu YF, et al. (2020) Sex-, age-, and race/ethnicity-dependent variations in drug-processing and NRF2-regulated genes in human livers. Drug Metabolism and Disposition: the Biological Fate of Chemicals |